Ellis Capital

Bert Ellis, as Chairman and CEO, is the sole decision-maker. The firm does not have an investment committee separate from Ellis himself — he originates deals, negotiates terms, and sits on the boards of portfolio companies. VP Administration Debra Davis handles operational and financial oversight but is not listed as an investment professional.

Ellis Capital does not disclose whether it manages third-party LP capital. The firm's website refers to "investors" and notes that Ellis has "achieved significant returns for his investors," but no fund structures or outside limited partners are publicly named. In practice, the firm operates more like a personal holding company than a traditional blind-pool venture fund — Ellis deploys his own liquidity, holds positions indefinitely, and takes board seats in portfolio companies.

The firm identifies media, telecommunications, internet technology, healthcare, social media, financial services, and real estate as its primary sectors. Confirmed portfolio companies include Vivex Biologics in regenerative medicine, Brightwell Payments in fintech, MAXEX in digital mortgages, and Semantic-AI in intelligence software. Ellis also invests in film production and holds an operating broadcast asset, which expands the practical mandate beyond pure venture.